ZILERAN

USPTO USPTO 2010 ABANDONED - NO STATEMENT OF USE FILED

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark ZILERAN was filed as Word mark on 01/06/2010 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - NO STATEMENT OF USE FILED".

Trademark Details Last update: June 15, 2018

Trademark form Word mark
File reference 77905797
Application date January 6, 2010
Publication date August 5, 2014

Trademark owner

2 CHURCH STREET
HM11 HAMILTON
BM

Trademark representatives

goods and services

5 Pharmaceutical preparations for the treatment of disorders, diseases, conditions and ailments, namely, eye drops, ophthalmic preparations, and pharmaceutical preparations for the treatment of eye diseases and the treatment of ocular disorders; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the central nervous system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Parkinson's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Huntington's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of amyotrophic lateral sclerosis; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Alzheimer's disease; Pharmaceutical preparations and substances for the prevention, treatment and alleviation of Tourette Syndrome; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of epilepsy; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the treatment of depression, depressive disorders and mental illnesses; antidepressants; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of anxiety; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of pain; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the cardiovascular system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of cardiopulmonary disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of hypertension, angina, high blood pressure, heart failure and ventricular dysfunction; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of metabolic disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of diabetes; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of viral and infectious diseases

ID: 1377905797